OTLK Stock Analysis: Buy, Sell, or Hold?
OTLK - Outlook Therapeutics, Inc. Common Stock
$0.81
0.00 (-0.47%)
▼
5d:
+38.31%
30d:
+208.5%
90d:
+84.68%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When OTLK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
58 traders called OTLK this week
95% bullish • 6 bearish
95% bullish • 6 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: OTLK is 39.6% above its trading range ($0.58). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: OTLK is 39.6% above its trading range ($0.58). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: OTLK is currently trading at $0.81, which is considered extended relative to its 30-day fair value range of $0.16 to $0.58.
Technical Outlook: Technically, OTLK is in a uptrend. Immediate support is located at $0.22, while resistance sits at $0.94.
Market Sentiment: OTLK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.17 (+414.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OTLK is in a uptrend. Immediate support is located at $0.22, while resistance sits at $0.94.
Market Sentiment: OTLK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.17 (+414.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.16 -
$0.58
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+39.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 414.5% below Wall St target ($4.17)
- WARNING: Recommendation downgraded due to 39.6% overvaluation
Trading Range Analysis
30-Day Trading Range
$0.16 -
$0.58
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.22
Resistance Level
$0.94
Current Trend
Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.04
Wall Street Target
$4.17
(+414.5%)
Revenue Growth (YoY)
658.3%
Share & Embed Analysis
Last updated: June 03, 2026 6:47 PM ET
Data refreshes hourly during market hours. Next update: 7:47 PM
Data refreshes hourly during market hours. Next update: 7:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OTLK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 55 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$118 | 53 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 59 HOLD |
